One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Machine Learning for Automated Interpretation of Fluorodeoxyglucose-Positron Emission Tomography Scans in Lymphoma.
Schoder, Heiko MD, MBA 1,
doi : 10.1200/JCO.24.00675
Neoadjuvant Chemotherapy in Colon Cancer: More Than Just an Optical Illusion.
Peng, Chengwei MD 1,; Kircher, Sheetal M. MD 1,
doi : 10.1200/JCO.24.00220
Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.
Reed, Damon R. MD 1,2,,; Tulpule, Asmin MD, PhD 1,; Metts, Jonathan MD 3; Trucco, Matteo MD 4,; Robertson-Tessi, Mark PhD 5; O'Donohue, Tara J. MD 1,; Iglesias-Cardenas, Fiorella MD, MS 1; Isakoff, Michael S. MD 6; Mauguen, Audrey PhD 7,; Shukla, Neerav MD 1,; Dela Cruz, Filemon S. MD 1,; Tap, William MD 2,; Kentsis, Alex MD, PhD 1,; Morris, Carol D. MD, MS 8; Hameed, Meera MD 9; Honeyman, Joshua N. MD 8,; Behr, Gerald G. MD 10; Sulis, Maria Luisa MD, MS 1; Ortiz, Michael V. MD 1,; Slotkin, Emily MD 1,
doi : 10.1200/JCO.23.02717
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
Kang, Yoon-Koo MD 1,,; Kim, Hyung-Don MD 1,; Yook, Jeong Hwan MD 2; Park, Young-Kyu MD 3; Lee, Jong Seok MD 4; Kim, Young-Woo MD 5; Kim, Jin Young MD 6; Ryu, Min-Hee MD 1,; Rha, Sun Young MD 7,; Chung, Ik Joo MD 8; Kim, In-Ho MD 9; Oh, Sang Cheul MD 10; Park, Young Soo MD 11; Cheong, Jae-Ho MD 12; Jeong, Oh MD 3; Heo, Mi Hwa MD 6; Kim, Hark Kyun MD 5,; Park, ChoHyun MD 13; Yoo, Chang Hak MD 14; Kang, Seok Yun MD 15; Zang, Dae Young MD 16; Jang, You Jin MD 17; Sul, Ji Young MD 18; Kim, Jong Gwang MD 19; Kim, Beom Su MD 2; Beom, Seung-Hoon MD 7; Hwang, Jun-Eul MD 8; Ryu, Seung Wan MD 20; Kook, Myeong-Cherl MD 5; Ryoo, Baek-Yeol MD 1; Kim, Hyunki MD 21; Yoo, Moon-Won MD 2; Lee, Nam Su MD 22; Lee, Sang Ho MD 23; Noh, Sung Hoon MD 24
doi : 10.1200/JCO.23.02167
Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose-Positron Emission Tomography.
Jemaa, Skander MS 1,,; Ounadjela, Souhila MD 1,; Wang, Xiaoyong PhD 1; El-Galaly, Tarec C. MD, DMSc 2,3,4,5; Kostakoglu, Lale MD 6,; Knapp, Andrea PhD 7,; Ku, Grace MD 1,; Musick, Lisa PharmD 1,; Sahin, Denis BSc 7; Wei, Michael C. MD, PhD 1,; Yin, Shen PhD 1,; Bengtsson, Thomas PhD 8,; De Crespigny, Alex PhD 1,; Carano, Richard A.D. PhD 1,
doi : 10.1200/JCO.23.01978
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.
Hu, Huabin MD 1,2,3; Zhang, Jianwei MD 1,2,3; Li, Yunfeng MD 4; Wang, Xiaozhong MD 5; Wang, Ziqiang MD 6; Wang, Hui MD 2,3,7; Kang, Liang MD 2,3,7; Liu, Ping MD 4; Lan, Ping MD 2,3,7; Wu, Xiaojian MD 2,3,7; Zhen, Yunhuan MD 8; Pei, Haiping MD 9; Huang, Zhongcheng MD 10; Zhang, Hao MD 11; Chen, Wenbin MD 12; Zeng, Yongming MD 13; Lai, Jiajun MD 14; Wei, Hongbo MD 15; Huang, Xuefeng MD 16; Chen, Jiansi MD 17; Chen, Jigui MD 18; Tao, Kaixiong MD 19; Xu, Qingwen MD 20; Peng, Xiang MD 21; Liang, Junlin MD 22; Cai, Guanfu MD 23; Ding, Kefeng MD 24; Ding, Zhijie MD 25; Hu, Ming MD 26; Zhang, Wei MD 27; Tang, Bo MD 28; Hong, Chuyuan MD 29; Cao, Jie MD 30; Huang, Zonghai MD 31; Cao, Wuteng MD 32; Li, Fangqian MD 32; Wang, Xinhua MD 32; Wang, Chao MD 33; Huang, Yan MD 33; Zhao, Yandong MD 33; Cai, Yue MD 1,2,3; Ling, Jiayu MD 1,2,3; Xie, Xiaoyu MD 1,2,3; Wu, Zehua MD 1,2,3; Shi, Lishuo PhD 34; Ling, Li PhD 35; Liu, Hao PhD 36; Wang, Jianping MD 2,3,7; Huang, Meijin MD 2,3,7; Deng, Yanhong MD, PhD 1,2,3,; on behalf of the OPTICAL study group; Deng, Yanhong; Li, Yunfeng; Wang, Ziqiang; Wang, Xiaozhong; Zhang, Ruyi; Pei, Haiping; Huang, Zhongcheng; Zhang, Hao; Chen, Wenbin; Zeng, Yongming; Lai, Jiajun; Wei, Hongbo; Huang, Xuefeng; Chen, Jiansi; Chen, Jigui; Tao, Kaixiong; Xu, Qingwen; Peng, Xiang; Liang, Junlin; Cai, Guanfu; Ding, Kefeng; Ding, Zhijie; Hu, Ming; Zhang, Wei; Tang, Bo; Hong, Chuyuan; Cao, Jie; Huang, Zonghai
doi : 10.1200/JCO.23.01889
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.
Dzienis, Marcin MD 1,,; Cundom, Juan MD 2,; Fuentes, Christian Sebastian MD 3; Spreafico, Anna MD 4,; Nordlinger, Melanie MD 5; Pastor, Andrea Viviana MD 6; Alesi, Erin MD 7; Neki, Anterpreet MD 8; Fung, Andrea S. MD, PhD 9,; Figueiredo Lima, Iane Pinto MD 10,; Oppelt, Peter MD 11,; da Cunha Junior, Geraldo Felicio PhD 12; Burtness, Barbara MD 13,; Franke, Fabio Andre MD 14; Tseng, Jennifer E. MD 15; Joshi, Abhishek MD 16,; McCarthy, Joy MD 17,; Swaby, Ramona MD 18,; Sidi, Yulia PhD 18,; Gumuscu, Burak MD, PhD 18,; Naicker, Niroshini MD 19,; de Castro, Gilberto Jr MD, PhD 20,
doi : 10.1200/JCO.23.02625
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial.
Camidge, D. Ross MD, PhD 1,,; Bar, Jair MD, PhD 2,; Horinouchi, Hidehito MD, PhD 3,; Goldman, Jonathan MD 4,; Moiseenko, Fedor MD, PhD 5,; Filippova, Elena MD 6,; Cicin, Irfan MD 7,; Ciuleanu, Tudor MD, PhD 8,; Daaboul, Nathalie MD 9,; Liu, Chunling MD 10; Bradbury, Penelope MD (UK), MB, BCh, FRACP 11,; Moskovitz, Mor MD 12,; Katgi, Nuran MD 13; Tomasini, Pascale MD 14,; Zer, Alona MD 12,; Girard, Nicolas MD, PhD 15,; Cuppens, Kristof MD 16,17,; Han, Ji-Youn MD, PhD 18,; Wu, Shang-Yin MD 19,20; Baijal, Shobhit MBBS BSc (Hons), MRCP 21,; Mansfield, Aaron S. MD 22,; Kuo, Chih-Hsi MD 23,; Nishino, Kazumi MD, PhD 24,; Lee, Se-Hoon MD, PhD 25,; Planchard, David MD, PhD 26,27,; Baik, Christina MD, MPH 28,; Li, Martha PhD 29,; Ansell, Peter PhD 29,; Xia, Summer PhD 29,; Bolotin, Ellen MD 29,; Looman, Jim MD 29,; Ratajczak, Christine PhD 29,; Lu, Shun MD, PhD 30
doi : 10.1200/JCO.24.00720
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy +/- 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.
Chavez-MacGregor, Mariana MD, MSc, FASCO 1,,; Miao, Jieling MS 2; Pusztai, Lajos MD, DPhil 3,; Goetz, Matthew P. MD 4,; Rastogi, Priya MD 5,; Ganz, Patricia A. MD 6,; Mamounas, Eleftherios P. MD 7,; Paik, Soonmyung MD 8,; Bandos, Hanna PhD 9,; Razaq, Wajeeha MD 10; O'Dea, Anne MD 11,; Kaklamani, Virginia MD 12,; Silber, Andrea L.M. MD 3,; Flaum, Lisa E. MD 13,; Andreopoulou, Eleni MD 14; Wendt, Albert G. MD 15,; Carney, Jennifer F. MD 16; Sharma, Priyanka MD 11,; Gralow, Julie R. MD 17; Lew, Danika L. MA 2; Barlow, William E. PhD 2,; Hortobagyi, Gabriel N. MD 1,
doi : 10.1200/JCO.23.02344
Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer.
Soldato, Davide MD 1,; Michiels, Stefan PhD 2,; Havas, Julie MS 1; Di Meglio, Antonio MD, PhD 1,; Pagliuca, Martina MD 1,3,; Franzoi, Maria Alice MD 1,; Pistilli, Barbara MD 4,; Iyengar, Neil M. MD 5,6,; Cottu, Paul MD, PhD 7,; Lerebours, Florence MD 8,; Coutant, Charles MD 9,; Bertaut, Aurelie MD, PhD 9; Tredan, Oliver MD, PhD 10; Vanlemmens, Laurence MD 11; Jouannaud, Christelle MD 12,; Hrab, Iona MD 13; Everhard, Sibille PhD 14; Martin, Anne-Laure PharmD 14; Andre, Fabrice MD, PhD 1,4,; Vaz-Luis, Ines MD, PhD 1,4,15,,; Jones, Lee W. PhD 5,6,
doi : 10.1200/JCO.23.01959
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Apolo, Andrea B. MD 1,; Girardi, Daniel M. MD 1,; Niglio, Scot A. MD 1; Nadal, Rosa MD, PhD 1; Kydd, Andre R. MD, PhD 1; Simon, Nicholas MD 1; Ley, Lisa MS, RN 1; Cordes, Lisa M. PharmD 1; Chandran, Elias MBBS 1; Steinberg, Seth M. PhD 2; Lee, Sunmin MS 3; Lee, Min-Jung PhD 3; Rastogi, Shraddha PhD 3; Sato, Nahoko MD, PhD 3; Cao, Liang PhD 4; Banday, A. Rouf PhD 1; Boudjadi, Salah MD, PhD 1; Merino, Maria J. MD 5; Toubaji, Antoun MD 5; Akbulut, Dilara MD 5; Redd, Bernadette MD 6,; Bagheri, Hadi MD 6,; Costello, Rene BS 1; Gurram, Sandeep MD 7; Agarwal, Piyush K. MD 7,; Chalfin, Heather J. MD 7,; Valera, Vladimir MD, PhD 7; Streicher, Howard MD 8; Wright, John Joseph MD, PhD 8; Sharon, Elad MD 8,; Figg, William D. PharmD, MBA 1,; Parnes, Howard L. MD 9,; Gulley, James L. MD, PhD 10,; Saraiya, Biren MD 11,; Pal, Sumanta K. MD 12,; Quinn, David MD 13,; Stein, Mark N. MD 14,; Lara, Primo N. MD 15,; Bottaro, Donald P. PhD 7,; Mortazavi, Amir MD 16,
doi : 10.1200/JCO.23.02233
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy.
Duke, Elizabeth S. MD 1,; Bradford, Diana MD 1; Sinha, Arup K. PhD 1; Mishra-Kalyani, Pallavi S. PhD 1; Lerro, Catherine C. PhD, MPH 2; Rivera, Donna PharmD, MSc 2; Wearne, Emily PhD 1; Miller, Claudia P. PhD 1; Leighton, John PhD 1,; Sabit, Hairat PhD 1,; Zhao, Hong PhD 1,; Lane, Ashley MS 1; Scepura, Barbara MSN 1; Pazdur, Richard MD 1; Singh, Harpreet MD 1,2; Kluetz, Paul G. MD 1,2; Donoghue, Martha MD 2; Drezner, Nicole MD 1,
doi : 10.1200/JCO.24.00546
Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.
Daly, Megan E. MD 1,; Singh, Navneet MD, DM, FASCO 2; Ismaila, Nofisat MD, MSc 3,; for the Management of Stage III NSCLC Guideline Expert Panel; Daly, Megan E. MD; Singh, Navneet MD, DM; Ismaila, Nofisat MD, MSc; Antonoff, Mara B. MD; Arenberg, Douglas A. MD; Bradley, Jeffrey MD; David, Elizabeth MD; Detterbeck, Frank MD; Fruh, Martin MD; Gubens, Matthew A. MD, MS; Moore, Amy C. PhD; Padda, Sukhmani K. MD; Patel, Jyoti D. MD; Phillips, Tanyanika MD, MPH; Qin, Angel MD; Robinson, Clifford MD; Simone, Charles B. II MD
doi : 10.1200/JCO-24-01324
Shorter Duration of Trastuzumab Combined With Chemotherapy for Early Breast Cancer.
Kusumoto, Misa MD; Shimomura, Akihiko MD, PhD; Shimizu, Chikako MD, PhD
doi : 10.1200/JCO.23.02407
Reply to M. Kusumoto et al.
Conte, Pierfranco MD; Guarneri, Valentina MD; D'Amico, Roberto MD
doi : 10.1200/JCO.23.02655
Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma.
Yin, Zhao MD; Zhang, Qing MD; Ou, Ruiming MD; Liu, Shuang MD
doi : 10.1200/JCO.24.00544
Erratum: Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials.
doi : 10.1200/JCO-24-01584
